Dongbang Medical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	104,670	162,528	-	-	-
Enterprise Value	106,099	166,596	-	-	-
Last Close Price	5000.00	7810.00	-	-	-
PE Ratio	7.61	13.89	-	-	-
Forward PE	-	7.99	-	-	-
PS Ratio	0.89	1.43	-	-	-
PB Ratio	0.79	1.30	-	-	-
P/TBV Ratio	0.82	1.36	-	-	-
P/OCF Ratio	8.11	13.52	-	-	-
EV/Sales Ratio	0.90	1.47	-	-	-
EV/EBITDA Ratio	4.17	7.16	-	-	-
EV/EBIT Ratio	5.81	10.25	-	-	-
Debt / Equity Ratio	0.22	0.27	0.54	0.59	0.81
Debt / EBITDA Ratio	1.13	1.43	2.01	1.41	3.18
Debt / FCF Ratio	-	-	8.03	17.64	7.86
Net Debt / Equity Ratio	-0.01	0.00	0.33	0.29	0.36
Net Debt / EBITDA Ratio	-0.04	-0.01	1.22	0.68	1.43
Net Debt / FCF Ratio	0.80	0.13	4.90	8.53	3.53
Asset Turnover	0.65	0.67	0.79	0.79	-
Inventory Turnover	2.03	2.12	2.29	2.22	-
Quick Ratio	1.27	1.19	0.73	0.68	0.61
Current Ratio	2.31	2.12	1.44	1.36	1.13
Return on Equity (ROE)	10.88%	11.11%	4.64%	20.18%	-
Return on Assets (ROA)	6.28%	6.03%	7.24%	9.31%	-
Return on Invested Capital (ROIC)	11.46%	11.21%	8.07%	21.00%	5.67%
Return on Capital Employed (ROCE)	12.30%	11.50%	15.50%	24.50%	9.20%
Earnings Yield	13.32%	7.20%	-	-	-
FCF Yield	-1.14%	-1.54%	-	-	-
Buyback Yield / Dilution	-22.92%	-28.29%	7.51%	-17.90%	-